Top 4 Health Care Stocks That May Plunge This Month
Top 4 Health Care Stocks That May Plunge This Month
As of April 26, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
截至2024年4月26日，医疗保健行业的四只股票可能会向将动量视为交易决策关键标准的投资者发出真正的警告。
The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, according to Benzinga Pro.
RSI是一个动量指标，它比较股票在价格上涨的日子里的走强与价格下跌的日子的走强。与股票的价格走势相比，它可以让交易者更好地了解股票在短期内的表现。根据Benzinga Pro的数据，当相对强弱指数高于70时，资产通常被视为超买。
Here's the latest list of major overbought players in this sector.
以下是该行业主要超买参与者的最新名单。
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN)
聚变制药公司（纳斯达克股票代码：FUSN）
- AstraZeneca, through a subsidiary, will acquire all of Fusion's outstanding shares for a price of $21.00 per share in cash at closing plus a non-transferable CVR representing the contingent right to receive $3.00/share in cash payable upon the achievement of a specified regulatory milestone, pursuant and subject to the terms and conditions of a contingent value rights agreement. The company's stock gained around 408% over the past six months and has a 52-week high of $21.55.
- RSI Value: 78.74
- FUSN Price Action: Shares of Fusion Pharmaceuticals closed at $21.40 on Thursday.
- 阿斯利康将通过子公司以收盘时每股现金21.00美元的价格收购Fusion的所有已发行股份，外加不可转让的CVR，代表在实现特定监管里程碑后获得每股3.00美元应付现金的或有权利，但须遵守或有价值权利协议的条款和条件。该公司的股票在过去六个月中上涨了约408％，创下52周高点21.55美元。
- RSI 值：78.74
- FUSN价格走势：Fusion Pharmicals的股价周四收于21.40美元。
AstraZeneca PLC (NASDAQ:AZN)
阿斯利康公司（纳斯达克股票代码：AZN）
- AstraZeneca reported first-quarter sales of $12.68 billion, up 17% year over year (+19% at constant currency), slightly below the consensus of $11.83 billion. The company's stock gained around 10% over the past five days and has a 52-week high of $75.81.
- RSI Value: 82.50
- AZN Price Action: Shares of AstraZeneca gained 5.4% to close at $75.03 on Thursday.
- 阿斯利康公布的第一季度销售额为126.8亿美元，同比增长17％（按固定汇率计算增长19％），略低于市场普遍预期的118.3亿美元。该公司的股票在过去五天中上涨了约10％，创下52周高点75.81美元。
- 相对强弱指数值：82.50
- AZN价格走势：周四，阿斯利康股价上涨5.4％，收于75.03美元。
Boston Scientific Corporation (NYSE:BSX)
波士顿科学公司（纽约证券交易所代码：BSX）
- On April 24, Boston Scientific reported better than expected first-quarter earnings and issued guidance. The company's stock gained around 8% over the past five days and has a 52-week high of $74.39.
- RSI Value: 76.34
- BSX Price Action: Shares of American Express gained 0.5% to close at $73.26 on Thursday.
- 4月24日，波士顿科学公布的第一季度收益好于预期，并发布了指引。该公司的股票在过去五天中上涨了约8％，创下52周高点74.39美元。
- RSI 值：76.34
- BSX价格走势：周四，美国运通股价上涨0.5％，收于73.26美元。
Elevance Health, Inc. (NYSE:ELV)
Elevance Health, Inc.（纽约证券交易所代码：ELV）
- On April 18, Elevance Health reported first-quarter revenues of $42.3 billion, up 0.9% year over year, marginally missing the consensus of $42.6 billion. "First quarter results reflect disciplined execution of our strategic initiatives during a dynamic time for our industry," CEO Gail Boudreaux said. "We are making significant progress expanding Carelon's capabilities, scaling our flywheel for enterprise growth, and delivering results for all stakeholders." The company's stock jumped around 4% over the past month and has a 52-week high is $542.07.
- RSI Value: 70.18
- ELV Price Action: Shares of Elevance Health gained 1.1% to close at $539.68 on Thursday.
- 4月18日，Elevance Health公布的第一季度收入为423亿美元，同比增长0.9％，略低于预期的426亿美元。首席执行官盖尔·布德罗说：“第一季度的业绩反映了我们在行业动态时期严格执行战略举措。”“我们在扩大Carelon的能力、扩大企业增长的飞轮以及为所有利益相关者交付成果方面正在取得重大进展。”该公司的股票在过去一个月中上涨了约4％，创下52周高点为542.07美元。
- 相对强弱指数值：70.18
- ELV价格走势：周四，Elevance Health的股价上涨1.1％，收于539.68美元。
Read More: Microsoft, Alphabet And 3 Stocks To Watch Heading Into Friday
阅读更多：进入周五，微软、Alphabet和3只股票值得关注